Dlqi
Dlqi
Dlqi
Skin disease has been recognized as having a detrimental Development of the DLQf
effect on the quality of life of patients.' ^ This psychoso-
cial aspect of skin disease has important implications for One hundred and twenty consecutive patients aged 15-70
optimal management of patients.^ Although dermatolo- years attending the Dermatology Out-Patient Depart-
gists and other clinicians have long recognized the impact ment, University Hospital of Wales, were given a sheet of
of skin disease on a patient's life, it is only recently that paper with the following question;
quality of life measures have been used as assessment We are trying to find out how much skin disease affects people. We
parameters in the management of chronic skin disease would he grateful if you could help us, though there is no obligation to
do so. Please could you write down all the ways that your skin
and in the evaluation of new rrcatmenrs." disease affects you. Please include any affects on your work life,
Disease-specific indices of disability have been devel- social life, personal relationships and leisure activities, or any other
oped to record the impact of atopic eczema, psoriasis and ways in which your skin disease aftects your life. Although we need a
acne,''"" but these cannot be used to compare different record of your diagnosis, sex and age for analysis, your reply is
skin diseases. In contrast, general health measures of otherwise anonymous.
quality of life, such as the United Kingdom Sickness No patient refused to answer.
Impact Profile (UKSIP), can be used to compare the Each answer was analysed by identifying different
aspects of life quality impairment. Tbe number of
Correspondence: Dr A.Y.Finlay, F.R.C.P., Senior Lecturer and different aspects identified in each answer ranged from 0
C-onsultant Dermatologist, Department of Dermatology, University
of Wales College of Medicine, Cardiff Cr4 4XN, Wales, UK, to 8. A total of 49 different aspects were identified, sorted
This paper was presented at the British Association of Dermatolo-
into different overall categories and then ranked accord-
gists and Canadian Dermatology Association Joint Annual Meeting, ing to their frequency of mention (Table 1). After the
Oxford, UK, 6-10 July 1993. analysis of the first 70 answers, no additional problems
210
OKRMA'rOLOGY LIFE QUALITY INDEX 211
Table I. DifTerent aspects of life impairment identified from answers Table 2. Details ofthe diagnoses of the 120 patients who provided tbe
given h\ 120 new out-patients with a range of skin diseases. information on which the D1.(^I was based
The aim of this questionnaire Is to measure how much your skin problem has
affected your life OVER THE LAST WEEK. Please tick • one box for each question.
1. Over the last week, how itchy, sore.
painful or stinging has your skin
Very much
A lot
been? A little
Not at all
2. Over the last week, how embarrassed Very much G
or self conscious have you been because A lot G
of your skin? A little G
Not at all G
3. Over the last week, how much has your Very much G
skin interfered with you going A lot G
shopping or looking after your home or A little G
garden? Not at all G Not relevant G
4. Over the last week, how much has your Very much G
skin influenced the clothes A lot G
you wear? A little G
Not at all G Not relevant G
5. Over the last week, how much has your Very much
A lot C
skin affected any social or
leisure activities? A Uttie C
Not at all C Not relevant G
6. Over the last week, how much has your Very much G
skin made It difficult for A lot G
you to do any sport? A little G
Not at all G Not relevant G
7. Over the last week, has your skin Yea G
Not relevant G
prevented you from working or No G
studying?
If "No", over the last week how much has A lot G
your skin been a problem at A little G
work or studying? Not at all G
8. Over the last week, how much has your Very much G
skin created problems with your A lot G
partner or any of your close friends A little G
or relatives? Not at all G Not relevant G
Table 3. Measurement of quality of life (DLQI) in 200 patients with a variety of skin diseases and 100 eontrols
Kange
Mean age Mean (s.d.) Mean (s.d.) DLQI
Diagnosis No. of patients Sex (years) D L Q I score DLQI score (%) score
1 -
0,8-I
0,6 -
0-4 -
0,2
0
4 5 6 7 8
DLQI question numbei- 0,8
Figure 2. The mean scores of each DLQI question for patients OLQI question number
(n = 200) and eontrols («=100).
Figure 3. Reliahlity of DLQI test-retest scores. (Correlation in 53
patients with a range of skin diseases.
Table 4. The consistency hetween paired DLQI questions using the Reliability
rank correlation teehnique. The higher the rank correlation value, the
greater the consistency hetween the questions Test-retest reliability correlation coefficients were
obtained using the Spearman rank correlation technique
Question 1 (Fig. 3). The correlation between overall DLQJ scores
was very high (y, = 0-99, /'<0-0001). The test-retest
0-33 reliability of individual question scores was also examined
0-33 0-32 and the correlations were also high (7^ —0-95-0'98,
0-36 043 0-35
0-35 0-53 0-58 0-57
0-27 0-45 0-51 0-45 0-70
0-38 0-34 041 0-23 0-43 0-38
0-43 045 0-40 0-39 0-53 0-39 0-47 Discussion
0-25 0-30 0-25 0-31 0-36 0-34 0-41 0-57
10 0-41 0-39 0-25 0-53 0-43 0-39 0-27 0-32 0-24 Methods of measuring disability caused by skin disease
are needed for several reasons; first, to provide a
DERMATOLOGY LIFE QUALITY INDEX 215
comparator with systemic diseases in discussions con- Tn general the DLQI was very reliable in its overall score
cerning resource allocation hetween medical specialities; as well as in individual questions.
second, to assess the effectiveness of new therapies; third, A 'leisure questionnaire' for use by dermatology
to use in audit ofthe effectiveness of dermatology clinical patients was proposed by Ryan'- to record impairment of
services; fourth, to provide an additional patient-oriented quality of life, though no overall scoring system was
measure of disease status for routine clinical monitoring, proposed nor was the origin or practical use of this
and fifth, to provide comparisons between the 'impor- questionnaire described. The 10 questions in the 'leisure
tance' of different skin diseases and the relative effective- questionnaire' are largely covered by questions 3, 5, 6 and
ness of therapy. 9 in the DLQI; the other six DLQI questions concern
Some of these needs can be met by previously areas not mentioned in the 'leisure questionnaire', but
described methods. The UKSIP provides a possible which were frequently mentioned by patients in the
comparator between different skin diseases and between survey on which the DLQI is based. When comparing
other systemic diseases. Novel therapies, used for specific the questions in the DLQI with those in thePDL and the
diseases, can be assessed using disease specific question- ADI^, it is clear that similar areas are covered; however, in
naires such as the Psoriasis Disability Index (PDI) or the the psoriasis and the acne measures there is a specific
Acne Disability Index (ADI).^'^ The need for measures in emphasis to the questions refiecting each disease, w hereas
the audit ofthe effectiveness of a dermatology service can the DLQI questions are more widely encompassing. It
only partly be met by the use of disease specific should be noted that the scoring system used for the
questionnaires as too many different instruments would DLQI, as for other similar questionnaires, is ultimately
need to be used, and the use of general health measures of arbitrary, and the scoring refiects the bias ofthe question
life quality may be impractical. These difficulties also selection. It is possible for example that patients from
apply in routine clinical use. C-omparison can be drawn other cultures might place a different emphasis on the
between different skin diseases by using the UKSIP but importance ofthe various aspects of handicap covered by
for extensive studies or ongoing monitoring a simpler the questionnaire.
technique is required. The DLQI has been designed to This questionnaire has been specifically designed to be
meet the need for a very simple but sensitive method of practical and to be of clinical value when used in a busy
measuring disability caused by skin diseases. It was clinical setting. The scoring system is therefore deliber-
completed rapidly and without difficulty by patients over ately simple and the information is most conveniently
a wide range of age and intellectual ability, usually in 1-3 summarized as an overall score. By definition, if the score
min. The DLQI, therefore, potentially fulfils the pre- of one question increases at the same time as the score of
viously unmet needs identified above. another question decreases, the overall score remains the
Time-scale is an important factor to be considered same: this is as intended as maintenance ofthe same score
when constructing questions in any measure of handicap. reflects an overall unchanged average level of quality of
We chose a 1-week time-scale as an appropriate time over life. It is possible of course, if required, to maintain and
which patients could easily remember events. This time- use the detailed information given in the replies by
scale is also short enough to allow the DLQI to be used analysing either each question or groups of questions
for comparative purposes in routine clinical use. separately. We have previously used this approach in
tn the first of a series of validation studies, we have grouping questions under five headings when analysing
established a construct validity for the questionnaire by data from the PDI.** A similar analysis ofthe DLQJ, using
initially measuring the quality of life of two different six headings, could group the 10 questions as follows:
groups, patients with skin disease and normal healthy
subjects. The questionnaire scores were able to discrimi- Symptoms, feelings 1,2
Daily activities 3,4
nate between these two groups.
The method of 'test-retest' reliability assessment Leisure 5,6
adopted in this study does not involve any observer or Work/school 7
Personal relationships 8,9
'rater','" and is therefore a preferred method of quantify-
ing the reproducibility of self-administered measures Treatment 10
such as the DLQI. The test-retest reliability of the
overall scores ofthe DLQI was consistent and high. The It is essential to demonstrate thar quality of life assess-
reliability correlations for the individual questions were ment methods can detect change in quality of life.
also consistent and high, but were slightly lower than that Measures of quality of life should not, for example, be
for the overall DLQI scores. This was expected, because used in clinical trials unless responsiveness has been
the reliability of assessment of one facet of dysfunction is demonstrated in the skin condition being examined. A
not likely to be as great as when all facets are included.^^ current study is using the DLQI to measure changes in
216 A.Y.FINLAY AND G.K.KHAN
quality of life before and after in-patient admission for Acknowledgments
skin disease (H.A.Kurwa and A.Y.Finlay, unpublished).
Preliminary analysis of the first 60 patients in this .study We wish to thank Dr M.S.Salek, Medicines Research
has demonstrated reduction in the mean DLQI from 14-3 Unit, University of Wales College of Cardiff and Dr
(before admission) to 8-4 (after admission), indicating R.G.Newcombe, Department of Medical Computing
that the DLQI is responsive to change. Clearly, however, and Statistics, University of Wales College of Medicine,
further responsiveness studies need to be carried out. for their helpful advice concerning this study.
External validity testing is also of importance, compar-
ing the results of the DLQI with other life quality
measures when used in parallel. Such an initial parallel References
assessment with the UKSIP is being carried out in a 1. Ryan TJ, Disability in dermatology. British Journal of Hospital
study designed to assess the effect of skin cancer on yVfe^inwe 1991; 46: 33-36.
quality of life (S.Blackford, D.L.Roberts, M.S.Salek and 2. Jowett S, Ryan TJ. Skin disease and handicap: an analysis ofthe
A.Y.Finlay, unpublished). We plan further external impact of skin conditions. Social Sciences and Medicine 1985; 20:
425-429.
validity testing with the UKSIP and the PDI. 3. Ginsberg IH, IJnk BG. Feeling of stigmatization in patients with
We have demonstrated previously that a very short psoriasis. Journal ofthe American Academy of Dermatology 1989;
disease-specific questionnaire^ can successfully be used in 20: 53-63.
routine clinical use to assess the impact of acne and its 4. Motley RJ, Finlay AY. Practical use of a disability index in the
treatment on patients' quality of life. We have now used a routine management of acne. Clinical and Experimental Dermato-
logy 1992; 17: 1-3.
new simple short questionnaire to compare quantitatively 5. Finlay AY, Salek MS, Khan GK et al. Quality of life improve-
the handicap experienced by patients with a wide range of ment in cyclosporin treated atopic dermatitis patients—a double
different skin diseases. As expected, this study has blind cross over study. British Journal of Dermatology, 1991; 125
confirmed that patients with chronic skin diseases such as (Suppl, 38): 16.
atopic eczema, psoriasis and acne experience a greater 6. Eun HC, Finlay AY. Measurement of atopic dermatitis disability.
Annals of Dermatology 1990; 2: 9-12.
impairment of quality of life than patients with moles and 7. Finlay AY, Kelly SE. Psoriasis—an index of disability. Clinical
seborrhoeie warts, which have little impact on a patient's and Experimental Dermatology 1987; 12: 8-11.
day to day activities. On the other hand it was surprising 8. Motley RJ, Finlay AY. How much disability is caused by acne?
that in this study patients with acne recorded less Clinical and Experimental Dermatology 1989; 14: 194-198.
impaired quality of life than patients with viral warts. 9. Finlay AY, Khan GK, Luscombc DK, Salek xMS, Validation of
This may reflect the selected nature of dermatology Sickness Impact Profile and Psoriasis Disability Index in psoria-
sis. British Journal of Dermatology 1990; 123: 751-756.
referrals seen at this secondary referral centre. 10, Streiner DL, Norman GR. Health Measurement Scales: A
We hope that the use of the DLQI in the routine Practical Guide lo their Development and Use. Oxford: Oxford
clinical assessment of patients with skin disease may make University Press, 1989.
the patient-physician interaction more patient-centred 11, Pollard WE, Bobbit RA, Bergner M el al. The Sickness Impact
Profile; reliability of a health status measure. Medieal Care 1976;
by highlighting the psychosocial influences on the indi- 14: 146-155.
vidual patient's well-being, as well as providing a useful 12, Ryan TJ. Tbe confident nude or whither dermatology. Dermato-
practical measure for regular use. logy m Practice 1987; 5: 8-18.